Cargando…
The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
PURPOSE: Interleukin (IL)-8 is a proinflammatory C-X-C chemokine involved in inflammation underling cardiac diseases, primary or in comorbid condition, such diabetic cardiomyopathy (DCM). The phosphodiesterase type 5 inhibitor sildenafil can ameliorate cardiac conditions by counteracting inflammatio...
Autores principales: | Giannattasio, S., Corinaldesi, C., Colletti, M., Di Luigi, L., Antinozzi, C., Filardi, T., Scolletta, S., Basili, S., Lenzi, A., Morano, S., Crescioli, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531405/ https://www.ncbi.nlm.nih.gov/pubmed/30415310 http://dx.doi.org/10.1007/s40618-018-0977-y |
Ejemplares similares
-
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
por: Di Luigi, Luigi, et al.
Publicado: (2016) -
Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte
por: Filardi, Tiziana, et al.
Publicado: (2019) -
Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications
por: Corinaldesi, C., et al.
Publicado: (2015) -
The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
por: Di Luigi, Luigi, et al.
Publicado: (2020) -
Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)